MODIFICATION
A -- Adjuvant Comparison and Characterization
- Notice Date
- 3/30/2021 7:32:51 AM
- Notice Type
- Solicitation
- NAICS
- 541714
— Research and Development in Biotechnology (except Nanobiotechnology)
- Contracting Office
- NIH NIAID DEA OA OFC ACQUISITIONS BETHESDA MD 20892 USA
- ZIP Code
- 20892
- Solicitation Number
- BAA-DAIT-75N93020R00022
- Response Due
- 9/16/2021 12:00:00 PM
- Archive Date
- 10/01/2021
- Point of Contact
- George Ralis, Contracting Officer, Phone: 2406695146, Tom Bahrami, Contracting Officer, Phone: 2406695147
- E-Mail Address
-
ralisg@niaid.nih.gov, bahramit@niaid.nih.gov
(ralisg@niaid.nih.gov, bahramit@niaid.nih.gov)
- Description
- The purpose of this Broad Agency Announcement (BAA) is to solicit proposals for a research program that includes the comparison of multiple adjuvants using various vaccine/antigen platforms. The comparative studies will establish immunological profiles (""immune fingerprints"") of adjuvants that work through different mechanisms to evaluate strength, quality, breadth, and durability of responses using: 1. ""omics"" technology platforms such as genomics, epigenomics, transcriptomics, RNAi screens, proteomics, metabolomics, lipidomics, and glycomics; 2. T cell functional assays (e.g., cytotoxicity, cytokine production, epitope specificity); and 3. B cell and antibody profiles to include assessment of isotype, avidity, epitope fine-specificity, and systems serology.
- Web Link
-
SAM.gov Permalink
(https://beta.sam.gov/opp/7ecb122e2b924d6aaa97cc76c2a3a8aa/view)
- Record
- SN05956602-F 20210401/210331083159 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |